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Although  primary  aldosteronism  had  been  recognized  to be  a treatable  type  of  hypertension,  it  was
recently  suggested  to be  associated  with  an increased  risk  of  cardiovascular  complications.  Coronary
artery  aneurysm  is  a rare  complication  after  drug-eluting  stent  (DES)  implantation,  and  a giant  coronary
aneurysm  is very  rare.  The  present  case  is a 51-year-old,  hypertensive  patient  with  primary  aldostero-
nism  who  developed  myocardial  infarction,  a giant  coronary  aneurysm  after  DES  implantation,  and  then
cerebral hemorrhage.  Our  case  suggests  the excessively  high  risk  for cardiovascular  complications  in
patients  with  primary  aldosteronism.rug-eluting stent <Learning  objective:  Primary  aldosteronism  had  been  recognized  to be  a  treatable  type  of hyperten-
sion.  However,  recent  studies  suggest  that  primay  aldosteronism  is associated  with  an  increased  risk  of
cardiovascular  complications  rather  than  essential  hypertension.  Coronary  artery  aneurysm  is a  rare  com-
plication  after  DES  implantation.  The  present  case  is a patient  with  primary  aldosteronism  who  developed
myocardial  infarction,  a giant  coronary  aneurysm  after  DES  implantation,  and  then  cerebral  hemorrhage,
thus  suggesting  the  excessively  high  risk  for cardiovascular  complications  in  primary  aldosteronism.>
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Primary aldosteronism had been recognized to be a treatable
ype of hypertension. However, recent studies suggest that primary
ldosteronism is associated with an increased risk of cardiovascular
omplications rather than essential hypertension [1,2]. The present
ase is a patient with primary aldosteronism who  developed
yocardial infarction (MI), a giant coronary aneurysm after drug-
luting stent (DES) implantation, and then cerebral hemorrhage,
hus suggesting the high risk for cardiovascular complications in
rimary aldosteronism.
ase report
The present case was  a 51-year-old man  who  had been hyper-
ensive since he was 35 years of age and he had been taking
0 mg/day nifedipine, 80 mg/day valsartan, and 50 mg/day spirono-
actone. He was referred to our hospital because of suspected
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878-5409/$ – see front matter © 2012 Japanese College of Cardiology. Published by Else
ttp://dx.doi.org/10.1016/j.jccase.2012.09.002secondary hypertension for hypokalemia (2.9 mmol/dl) at 45 years
of age. However, plasma renin and aldosterone levels were
2.6 ng/ml/h and 25.1 pg/ml, respectively, and abdominal ultra-
sound sonography did not detect any adrenal mass or renal artery
stenosis. He suddenly experienced chest pain for the ﬁrst time at
47 years of age. He had no coronary risk factor except for hyper-
tension, but his blood pressures had been around 130/80 mmHg
on medication. He had no history of smoking, and his total choles-
terol, low-density lipoprotein cholesterol, high-density lipoprotein
cholesterol, and hemoglobin A1c levels were 190 mg/dl, 122 mg/dl,
46 mg/dl, and 5.4%, respectively. His electrocardiogram showed
ST-segment elevation in leads II, III, and aVF. He was diag-
nosed to have acute inferior MI.  Emergent coronary angiography
revealed total occlusion at the middle site of the right coro-
nary artery (RCA) and severe narrowings at the proximal site of
the left anterior descending artery (LAD) and at the ﬁrst diag-
onal branch (D1). Primary percutaneous coronary intervention
(PCI) with a bare metal stent (4.0/23 mm,  Multi-Link VisionTM,
Abbott, Abott Park, IL, USA) implantation was performed for
the RCA occlusion. Elective PCI to the LAD and D1 narrowings
was also performed 1 week later with sirolimus-eluting stents
(3.0/33 mm and 3.0/18 mm,  CypherTM, Cordis, Miami Lakes, FL,
vier Ltd. All rights reserved.
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Fig. 1. Coronary angiography and intravascular ultrasound (IVUS). (A) Coronary angiography revealed severe narrowings (arrows) at the proximal site of the left anterior
descending artery (LAD) and at the ﬁrst diagonal branch (D1) (left panel). Percutaneous coronary intervention to the LAD and D1 narrowings was performed with sirolimus-
eluting  stents (CypherTM) implantation (right panel). IVUS revealed complete stent strut apposition at the stented site of the LAD. Arrow heads indicate stent strut. (B) Three
years  after acute myocardial infarction, coronary angiography revealed giant coronary artery aneurysm formation (arrows) at the stented site of the LAD with total occlusion
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cf  the D1. IVUS revealed stent malapposition and a giant aneurysm formation at th
SA) implantation (Fig. 1A). Complete stent strut apposition was
onﬁrmed by intravascular ultrasound (IVUS) (Fig. 1A). He was  dis-
harged on dual antiplatelet therapy and 10 mg/day atorvastatin
ithout any in-hospital events. His blood pressures were around
30/80 mmHg  on anti-hypertensive drugs (10 mg/day carvedilol,
0 mg/day nifedipine, 80 mg/day valsartan, and 25 mg/day spirono-
actone).
He presented to the emergency room with chest pain again
t 50 years of age. Although his electrocardiogram showed no
T-segment elevation, emergent coronary angiography revealed a
iant coronary aneurysm formation at the stented site of the LAD
ith the total occlusion of the D1 (Fig. 1B). IVUS also revealed stent
alapposition and a giant aneurysm formation at the stented site
f the LAD (Fig. 1B). However, no aneurysm formation was  found at
he stented site of the RCA. PCI for the D1 occlusion failed to achieve
eperfusion. Three days later, coronary computed tomography (CT)
emonstrated a giant coronary artery aneurysm (19 mm  in diam-
ter, 29 mm in length) with stent malapposition and thrombus at
he stented site of the LAD (Fig. 2). Anticoagulation therapy with
arfarin was started to prevent thrombus formation within coro-
ary aneurysm, and the international normalized ratio (INR) was
round 2.0. Three months later, CT showed no change in the size of
oronary artery aneurysm.ted site of the LAD. Arrow heads indicate stent strut.
He complained of sudden headache, gait disturbance, and
dysarthria at 51 years of age. He was  diagnosed to have brain
stem hemorrhage by brain CT, but the INR was 1.5. At the time
of this admission, plasma levels of low renin (0.3 ng/ml/h) and high
aldosterone (436.0 pg/ml) suggested primary aldosteronism. Both
furosemide provocation and captril challenge tests were positive.
Abdominal CT demonstrated a right adrenal mass (13 mm  × 9 mm),
which also showed abnormally increased uptake of 131I-adosterol
on adrenal scintigrams (Fig. 3). He underwent right adrenalectomy,
and he was  ﬁnally diagnosed as having primary aldosteronism due
to adrenal adenoma.
Discussion
Although primary aldosteronism had been recognized as a
treatable type of hypertension, it was recently suggested to be
associated with increased risk of cardiovascular complications
[1,2]. Milliez et al. investigated cardiovascular events in 124
patients with primary aldosteronism and 465 with essential
hypertension [1].  They reported the prevalence of stroke and MI  to
be higher in primary aldosteronism than in essential hypertension.
Catena et al. also showed the prevalence of cardiovascular events
to be higher in 54 patients with primary aldosteronism than in 323
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Fig. 2. The volume-rendered (upper panel) and curved and axial multiplanar ref-
ormation images (lower panels) of coronary computed tomography (CT). Coronary
CT  demonstrated a giant coronary aneurysm (19 mm in diameter, 29 mm in length)
(red arrow) with stent malapposition and thrombus (yellow arrow) at the stented
site  of left anterior descending artery (LAD). CT also showed the reopened D1 as
well as the stent fracture at D1 (arrow head), suggesting that D1 occlusion would
be  caused by stent fracture and giant coronary aneurysm.
Fig. 3. Abdominal computed tomography (CT) and 131I-adosterol scintigraphy. Abdomin
had  abnormally increased uptake of 131I-adosterol on adrenal scintigrams (right panel). Alogy Cases 7 (2013) e11–e14 e13
with essential hypertension [2].  Excess aldosterone levels were
reported to induce oxidative stress, inﬂammation, endothelial
dysfunction, and increased arterial stiffness [3–6]. The current
case with primary aldosteronism developed MI,  a giant coronary
aneurysm after DES implantation, and then cerebral hemorrhage.
These ﬁndings and the current case suggest the excessively high
risk for cardiovascular complications in primary aldosteronism.
Coronary aneurysms were reported to be a rare complica-
tion after DES implantation (1%), and a giant aneurysm (>8 mm
in diameter) is much rarer [7,8]. Anandaraja et al. reported a
giant coronary aneurysm (8 mm × 35 mm)  after DES  (TAXUSTM,
Boston Scientiﬁc, Natick, MA,  USA) implantation [9].  Okamura et al.
also reported a giant coronary aneurysm (8 mm × 17 mm)  after
DES (CypherTM) implantation [10]. The mechanism for coronary
aneurysm formation after DES implantation remains unknown,
but extensive acute vessel damage during the PCI procedure,
hypersensitivity reactions to DES, infectious processes, and late-
acquired malapposition with excessive vessel remodeling may  be
implicated [7,8]. The current case with primary aldosteronism
developed a giant coronary artery aneurysm (19 mm ×29 mm)
after DES implantation. Although there has been no reported case
with coronary aneurysm associated with primary aldosteronism,
excessive oxidative stress and inﬂammation in primary aldos-
teronism may  have contributed to this giant coronary aneurysm
formation [4–6]. Since coronary aneurysms with a diameter of
>30 mm are suggested to be at high risk for rupture, such
aneurysms should be surgically treated [11]. Moreover, no rup-
tured coronary aneurysm after DES implantation has been reported.
Therefore, our case was  followed medically without surgical resec-
tion. However, since the prognosis of coronary aneurysms after
DES implantation remains unknown, we will carefully follow this
case.
Primary aldosteronism is associated with increased cardio-
vascular complications, and it can be effectively treated with
adrenalectomy [2],  thus it is important to diagnose and treat
primary aldosteronism in a timely manner for hypertensive
patients.
al CT demonstrated a right adrenal mass (13 mm ×9 mm)  (left panel), which also
rrows indicate adrenal mass.
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